logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Parkinson Disease

    Medications for Parkinson Disease

    FiltersReset Filters
    39 results
    • amantadine

      (amantadine)
      Medication Details
      Alembic Pharmaceuticals Inc.
      Usage: Amantadine hydrochloride capsules are indicated for prophylaxis and treatment of influenza A virus infections and for treating parkinsonism and drug-induced extrapyramidal reactions. They are recommended during influenza outbreaks and in patients exhibiting parkinsonism symptoms, although they are less effective than some other treatments for Parkinson's disease.
      Medication Details
      Drug Interactions
    • amantadine hcl

      (AMANTADINE HYDROCHLORIDE)
      Medication Details
      Bionpharma Inc.
      Usage: Amantadine Hydrochloride Capsules are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for managing parkinsonism and drug-induced extrapyramidal reactions. Prophylaxis assists immune response development, but it’s not a substitute for vaccination. Effectiveness for other viral illnesses is not established.
      Medication Details
      Drug Interactions
    • amantadine hydrochloride

      (amantadine hydrochloride)
      Medication Details
      Upsher-Smith Laboratories, LLC
      Usage: Amantadine hydrochloride tablets are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for treating parkinsonism and drug-induced extrapyramidal reactions. It supports immune response development post-vaccination and is specifically effective in uncomplicated respiratory illnesses due to influenza A.
      Medication Details
      Drug Interactions
    • amantadine hydrochloride

      (Amantadine Hydrochloride)
      Medication Details
      Chartwell RX, LLC
      Usage: Amantadine hydrochloride oral solution is indicated for the prophylaxis and treatment of influenza A virus infections, as well as for treating Parkinson's disease and drug-induced extrapyramidal reactions. It is not a substitute for vaccination and may have limitations in efficacy due to resistance mutations in influenza viruses.
      Medication Details
      Drug Interactions
    • amantadine hydrochloride

      (Amantadine Hydrochloride)
      Medication Details
      Advagen Pharma Limited
      Usage: Amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions. It is not a substitute for vaccination and is less effective than levodopa for Parkinson's disease.
      Medication Details
      Drug Interactions
    • azilect

      (Rasagiline mesylate)
      Medication Details
      Teva Neuroscience, Inc.
      Usage: AZILECT (rasagiline tablets) is indicated for the treatment of Parkinson’s disease (PD).
      Medication Details
      Drug Interactions
    • bromocriptine mesylate

      (Bromocriptine mesylate)
      Medication Details
      Zydus Pharmaceuticals USA Inc.
      Usage: Bromocriptine mesylate capsules are indicated for treating hyperprolactinemia-related disorders (e.g., amenorrhea, infertility, hypogonadism), acromegaly, and symptoms of Parkinson's disease. It may be used with levodopa to enhance efficacy and reduce side effects, especially in patients experiencing tolerance or "end of dose failure."
      Medication Details
      Drug Interactions
    • bromocriptine mesylate

      (Bromocriptine mesylate)
      Medication Details
      Sandoz Inc
      Usage: Bromocriptine mesylate tablets are indicated for treating hyperprolactinemia-related dysfunctions (e.g., amenorrhea, infertility), acromegaly, and symptoms of Parkinson's disease. They help reduce tumor size in prolactin-secreting adenomas and enhance effects of levodopa in Parkinson's, while potentially reducing levodopa dosage and adverse reactions.
      Medication Details
      Drug Interactions
    • carbidopa and levodopa

      (Carbidopa and levodopa)
      Medication Details
      Advagen Pharma Ltd
      Usage: Carbidopa and levodopa extended-release tablets are indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism resulting from carbon monoxide or manganese intoxication.
      Medication Details
      Drug Interactions
    • carbidopa and levodopa

      (carbidopa and levodopa)
      Medication Details
      Rising Pharma Holdings, Inc.
      Usage: Carbidopa and levodopa orally disintegrating tablets are indicated for treating Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism following carbon monoxide or manganese intoxication. Carbidopa enhances levodopa’s effectiveness by reducing peripheral decarboxylation and may also lessen nausea, allowing for quicker dosage adjustments.
      Medication Details
      Drug Interactions